Related Experiment Video
Updated: Feb 5, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Bowel Biofilms: Tipping Points between a Healthy and Compromised Gut?
Hanne L P Tytgat1, Franklin L Nobrega2, John van der Oost3
1Laboratory of Microbiology, Wageningen University, 6708 WE Wageningen, The Netherlands; Institute of Microbiology, Swiss Federal Institute of Technology, ETH Zurich, 8093 Zurich, Switzerland.
Polymicrobial biofilms in the gut may signal disease development. Differentiating these bacterial communities is key for understanding gut health and disease states.
Area of Science:
- Microbiology
- Gastroenterology
- Human Health
Background:
- Bacterial communities significantly influence human health and disease.
- Mixed-species biofilms, often pathogenic, are implicated in dental, gastric, intestinal diseases, chronic wounds, and colon cancer.
- The presence of thick, polymicrobial biofilms in healthy gut mucosa, outside the appendix, remains a subject of debate.
Purpose of the Study:
- To explore the role of polymicrobial biofilms in gut health and disease.
- To investigate biofilms as potential early warning signals for gut mucosal disease.
- To highlight the importance of distinguishing microcolonies from biofilms for accurate reporting.
Main Methods:
- Literature review on bacterial communities and biofilms in the gut.
- Analysis of existing research on polymicrobial biofilms in various gastrointestinal conditions.
- Discussion of criteria for differentiating microcolonies and biofilms.
Main Results:
- Polymicrobial biofilms containing potential pathogens may indicate an early stage of disease.
- These biofilms can represent a critical transition point between a healthy and diseased gut mucosal state.
- Specific biofilm-forming pathogens and molecules show potential as diagnostic biomarkers.
Conclusions:
- Polymicrobial biofilms in the gut mucosa are significant indicators of health and disease.
- Identifying and characterizing these biofilms are crucial for early disease detection and management.
- Establishing clear criteria to differentiate microcolonies from biofilms is essential for future research and clinical application.
Related Concept Videos
Biofilms
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

